News about Global Pharma

Emcure Pharma Incorporates New Subsidiary Emcure Wellness to Widen Portfolio

Emcure Pharmaceuticals has announced the incorporation of a new wholly-owned subsidiary (WoS) named Emcure Wellness Private Limited in Pune, Maharashtra.

Global Pharma | 07/07/2025 | By Manvi |  613

Godavari Biorefineries' Patent for Anti-Cancer Molecule Now Validated in Spain, UK, and as a Unitary Patent Covering Multiple EU Member States

Godavari Biorefineries Ltd. has announced the validation of its European patent for a novel anti-cancer molecule in Spain, the UK, and as a Unitary Patent across multiple EU countries, marking a key milestone in its expansion into clinical-stage biotech and innovative cancer therapies.

Global Pharma | 07/07/2025 | By Mrinmoy Dey |  133

Pharma Faces $230 Billion Patent Cliff by 2030, Urging Strategic Shifts Amid Biosimilar Surge

Bristol Myers Squibb is likely to be among the hardest hit, with both Eliquis and Opdivo—major revenue contributors—set to go off-patent. GlobalData analyst George El-Helou notes that more than half of the top 15 pharma companies may struggle to absorb the impact, though some firms are leveraging promising pipeline drugs to cushion the blow.
<br />

Global Pharma | 07/07/2025 | By Darshana |  363

PM Modi Meets Cuban President at BRICS 2025, Discuss Strengthening Pharma Links

Prime Minister Modi proposed that Cuba recognise the Indian pharmacopoeia, a move that would pave the way for greater access to Indian generic medicines.

Global Pharma | 07/07/2025 | By Manvi |  312

GACL Flags Off First Consignments of Benzyl Alcohol and Benzaldehyde from New Plant in Dahej

Gujarat Alkalies and Chemicals Limited (GACL) marked another significant milestone on July 5, 2025, flagging off its first consignments of Benzyl Alcohol (BOH) and Benzaldehyde (BCHO) from its newly commissioned Chlorotoluenes plant at Dahej.

Global Pharma | 07/07/2025 | By Manvi |  377

India's Pharma Industry Poised to Surge to USD 130 Bn by 2030, Says IDMA South VP at Pharmac South Expo

India's pharmaceutical industry is set for exponential growth, with projections reaching USD 130 billion by 2030, said IDMA South VP T. Ravichandiran at the Pharmac South Expo 2025.

Global Pharma | 05/07/2025 | By Manvi |  259

PHARMASEAL and Viedoc Enter into Technical Integration Partnership

PHARMASEAL has announced a technology integration partnership with Viedoc to combine its Engility Trial Management Platform with Viedoc’s EDC solutions, offering life sciences companies a unified, cloud-based ecosystem to streamline clinical trial operations and improve data interoperability.

Global Pharma | 05/07/2025 | By Mrinmoy Dey |  189

FDA Approves Thermo Fisher's Oncomine Dx Express Test as Companion Diagnostic for ZEGFROVY

Thermo Fisher Scientific announced the US Food and Drug Administration (FDA) has approved the Oncomine™ Dx Express Test on the Ion Torrent™ Genexus™ Dx Integrated Sequencer as an in vitro diagnostic (IVD) assay for use as a companion diagnostic (CDx) for Dizal’s ZEGFROVY® (sunvozertinib) and in tumor profiling.

Global Pharma | 05/07/2025 | By Manvi |  152

India, Trinidad and Tobago Sign 6 MoUs to Boost Bilateral Cooperation, Including in Pharma

India has signed six Memoranda of Understanding (MoUs) with Trinidad and Tobago to enhance cooperation across several key sectors, including pharmaceuticals.

Global Pharma | 05/07/2025 | By Manvi |  309

Henlius, HanchorBio Partner to Develop HCB101 for Tumour Immunotherapy

Shanghai Henlius Biotech has entered a strategic partnership with HanchorBio’s subsidiary FBD Biologics to license and develop HCB101, a novel SIRPα-Fc fusion protein for tumour immunotherapy, with exclusive rights in China, Southeast Asia, and MENA.

Global Pharma | 05/07/2025 | By Mrinmoy Dey |  235